Rani Therapeutics (NASDAQ: RANI) has announced the promotion of Alireza Javadi, PhD, to chief technical officer.
Prior to the promotion to CTO, Dr. Javadi served as Rani’s VP, technical operations, where he was responsible for R&D, manufacturing, and automation teams. According to Rani, in this expanded role, he will continue to lead these core functions while also assuming responsibility for quality assurance. Before joining Rani in 2022, Dr. Javadi spent five years as director of operations at Cretex Medical.
In a statement, Talat Imran, CEO of Rani, commented, “We are thrilled to announce Alireza’s promotion to CTO as we enter an exciting era for Rani, highlighted by our collaboration with Chugai and our newly initiated Phase 1 study of RT-114 for the treatment of obesity. His technical and operational leadership experience in the medical device and life science industries will be instrumental in scaling our supply chain and manufacturing capabilities as we continue to advance our pipeline.”
